These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 15930344)

  • 1. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
    Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
    Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical characteristics of duodenal adenomas in familial adenomatous polyposis with special reference to cell kinetics.
    Esaki M; Matsumoto T; Yao S; Nakamura S; Hirahashi M; Yao T; Iida M
    Hum Pathol; 2005 Jan; 36(1):66-73. PubMed ID: 15712184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of extracellular E-cadherin in the normal mucosa of duodenum and colon of patients with familial adenomatous polyposis.
    Berkhout M; Gosens MJ; Brouwer KM; Peters WH; Nagengast FM; van Krieken JH; Nagtegaal ID
    Hum Pathol; 2006 Nov; 37(11):1389-99. PubMed ID: 16949915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of O6-methylguanine-DNA methyltransferase in colorectal neoplasms in sporadic and familial adenomatous polyposis patients.
    Kim SH; Bae SI; Lee HS; Kim WH
    Mol Carcinog; 2003 May; 37(1):32-8. PubMed ID: 12720298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesis.
    Subramaniam MM; Chan JY; Soong R; Ito K; Yeoh KG; Wong R; Guenther T; Will O; Chen CL; Kumarasinghe MP; Ito Y; Salto-Tellez M
    Am J Gastroenterol; 2009 Feb; 104(2):426-36. PubMed ID: 19174785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis.
    Keller JJ; Offerhaus GJ; Drillenburg P; Caspers E; Musler A; Ristimäki A; Giardiello FM
    Clin Cancer Res; 2001 Dec; 7(12):4000-7. PubMed ID: 11751493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 expression in FAP patients carrying germ line MYH mutations.
    Frattini M; Carnevali I; Signoroni S; Balestra D; Moiraghi ML; Radice P; Varesco L; Gismondi V; Ballardini G; Sala P; Pierotti MA; Pilotti S; Bertario L
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2049-52. PubMed ID: 16103460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa.
    Wagner PL; Chen YT; Yantiss RK
    Am J Surg Pathol; 2008 Sep; 32(9):1388-95. PubMed ID: 18670349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin expression is homogeneously reduced in adenoma from patients with familial adenomatous polyposis: an immunohistochemical study of E-cadherin, beta-catenin and cyclooxygenase-2 expression.
    Jungck M; Grünhage F; Spengler U; Dernac A; Mathiak M; Caspari R; Friedl W; Sauerbruch T
    Int J Colorectal Dis; 2004 Sep; 19(5):438-45. PubMed ID: 14986031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small-intestinal involvement in familial adenomatous polyposis: evaluation by double-balloon endoscopy and intraoperative enteroscopy.
    Matsumoto T; Esaki M; Yanaru-Fujisawa R; Moriyama T; Yada S; Nakamura S; Yao T; Iida M
    Gastrointest Endosc; 2008 Nov; 68(5):911-9. PubMed ID: 18561922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients.
    Kennedy BP; Soravia C; Moffat J; Xia L; Hiruki T; Collins S; Gallinger S; Bapat B
    Cancer Res; 1998 Feb; 58(3):500-3. PubMed ID: 9458096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?
    Levi E; Stryker SJ; Rao MS
    Am J Gastroenterol; 1996 Jan; 91(1):11-4. PubMed ID: 8561108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
    Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High resolution endoscopy and the additional value of chromoendoscopy in the evaluation of duodenal adenomatosis in patients with familial adenomatous polyposis.
    Dekker E; Boparai KS; Poley JW; Mathus-Vliegen EM; Offerhaus GJ; Kuipers EJ; Fockens P; Dees J
    Endoscopy; 2009 Aug; 41(8):666-9. PubMed ID: 19670132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial adenomatous polyposis is associated with a marked decrease in alkaline sphingomyelinase activity: a key factor to the unrestrained cell proliferation?
    Hertervig E; Nilsson A; Björk J; Hultkrantz R; Duan RD
    Br J Cancer; 1999 Sep; 81(2):232-6. PubMed ID: 10496347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
    Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal prostanoid receptors and synthesis in familial adenomatous polyposis.
    Takafuji V; Lublin D; Lynch K; Roche JK
    Histochem Cell Biol; 2001 Aug; 116(2):171-81. PubMed ID: 11685545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of familial juvenile polyps expressing cyclooxygenase-2.
    Brazowski E; Rozen P; Misonzhnick-Bedny F; Gitstein G
    Am J Gastroenterol; 2005 Jan; 100(1):130-8. PubMed ID: 15654792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detoxification enzyme polymorphisms are not involved in duodenal adenomatosis in familial adenomatous polyposis.
    Berkhout M; Roelofs HM; te Morsche RH; Dekker E; van Krieken JH; Nagengast FM; Peters WH
    Br J Surg; 2008 Apr; 95(4):499-505. PubMed ID: 18161889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.